Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Orca Bio to Present Clinical Data on Its High-Precision Cell Therapies at the 66th American Society of Hematology Annual Meeting
-
Ensoma Unveils Three Programs Leveraging In Vivo Hematopoietic Stem Cell Engineering Platform to Target Genetic, Immune and Oncological Diseases
-
City of Redmond to Streamline Capital Program Management Using Aurigo Masterworks
-
Versor Investments Wins Best Global Equity Strategy at HFM U.S. Hedge Fund Performance Awards
-
US STRATEGIC METALS RECEIVES FEDERAL APPROVAL OF $100.8 MILLION LOAN PROGRAM
-
Arthur J. Gallagher & Co. Acquires Peabody Insurance Agency, Inc.
-
The Beekman Group Announces the Sale of Riccobene Family Dentistry, a Leading Dental Service Organization in the Southeast Region
-
Cohen Industrial Supply Co. Rebrands as Freedom Waterworks, Signaling Growth and Renewed Commitment to Excellence
-
Lightbits Now Certified on Oracle Cloud Infrastructure
-
DreamHost Announces Partnership with E-Commerce Solution Provider Ecwid by Lightspeed
-
SynFutures Introduces the First 'Perp Launchpad' with $1M Grant to Support Emerging Token Projects
-
Opsys Collaborates with Curiosity Lab and City of Peachtree Corners to Launch Solid-State LiDAR Technology
-
North Carolina Entrepreneur Celebrates the Women in Whiskey With the Launch of Lythgoe® Bourbon
-
Visionet strengthens European presence with the strategic acquisition of Rödl Dynamics
-
Seismic Therapeutic Announces Presentations at Upcoming Scientific and Medical Conferences
-
FortisBC Inc. joins General Fusion's Market Development Advisory Committee to examine potential for fusion energy deployment
-
Ken Marks Joins Cynomi as Chief Revenue Officer
-
Arcus Biosciences Announces that Domvanalimab Plus Zimberelimab Improved Overall Survival in ARC-10, a Randomized Study in Patients with PD-L1-High Non-Small Cell Lung Cancer
-
Syndax Announces New Data from Secondary Analysis of the Pivotal AGAVE-201 Trial of Niktimvo™ (axatilimab-csfr) in Chronic Graft-Versus-Host Disease to Be Presented at 66th ASH Annual Meeting
-
RCI Announces Divestiture of Three Underperforming Bombshells
-
Quantum-Si to Participate in Upcoming Investment Conferences
-
CoStar Group Calls for Entries Ahead of Fourth Annual CoStar Impact Awards
-
Exactech Showcases Advanced Vitamin E Polyethylene and Technologies for Knee and Hip Replacement Surgery at AAHKS 2024
-
Defense Logistics Agency Selects Tetra Tech for Its $12 Billion Enterprise Technology Services Multiple-Award Contract
-
J.B. Hunt Transport Services, Inc. Announces Participation in Upcoming Investor Conferences
-
Seanergy Maritime Reports Third Quarter and Nine Months Financial Results for the Periods Ended September 30, 2024
-
Global-e to Announce Financial Results for the Third Quarter 2024 on November 20, 2024
-
Bybit Powered by SATOS Introduces Exclusive Referral Bonuses for Dutch Users
-
Blink to establish a £100 million Special Purpose Vehicle to Drive Electric Vehicle Charger Investments, Engaging Axxeltrova Capital as First Funding Partner
-
Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024 in One Oral Presentation and Three Poster Presentations
-
PrognomiQ Announces $34 Million Series D Financing to Advance Development of Early Detection Test for Lung Cancer with Multi-omics Platform
-
NeurAxis to Host Third Quarter 2024 Results and Business Update Call on Tuesday, November 12, 2024
-
FortisBC Inc. joins General Fusion's Market Development Advisory Committee to examine potential for fusion energy deployment
-
Kronos Bio to Present Data at the ASH Annual Meeting from p300 KAT Inhibition Program in Multiple Myeloma
-
Disc Medicine Announces Multiple Presentations Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting
-
Cartesian Therapeutics Announces Presentation at the Upcoming 66th ASH Annual Meeting
-
C4 Therapeutics to Present Data from the Ongoing Phase 1/2 Trial of Cemsidomide in Multiple Myeloma and Non-Hodgkin’s Lymphoma at the American Society of Hematology (ASH) Annual Meeting
-
Beam Therapeutics to Present Data Across Hematology Franchise, Including First Clinical Data for BEAM-101 in Sickle Cell Disease and ESCAPE Non-human Primate Data, at American Society of Hematology (A
-
Century Therapeutics Announces Upcoming Poster Presentations at the 2024 American Society of Hematology (ASH) Annual Meeting
-
i2i Population Health and CureMD Form Strategic Partnership to Advance Population Health Management and EHR Integration
-
Pangea Launches Two New Advanced Materials
-
kama.ai Supports Community Circle’s OWL Project with Responsible AI for Sustainable Water Solutions
-
Pacific Eye Associates Selects Nextech
-
GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024
-
Kaiser Aluminum Corporation to Participate in Baird’s 2024 Global Industrial Conference
-
PRIDE Industries Achieves AS9100 Certification, Strengthening its Position in Aerospace and Defense Manufacturing
-
ImCheck to Present Updated Data from the EVICTION Trial at the 39th Annual Meeting of the Society for Immunotherapy of Cancer
-
John Snyder, Former BCD CEO and Travel Industry Leader, Joins Oversee’s Advisory Board
-
THE RICHMAN GROUP CLOSES AFFORDABLE HOUSING TAX FUND TOTALING $171.5 MILLION IN EQUITY
-
New Manhattan Storage Facility Under Manhattan Mini Storage Third Party Management
